Phase 2-3 Clinical Trial Services
Clinilabs Drug Development Corporation, the only global, full-service contract research organization (CRO) focused exclusively on central nervous system (CNS) drug development, offers a full range of high quality, timely and cost-effective phase 2-3 clinical drug development services to help our customers speed new CNS medications to market. We are experts in and committed to the development of CNS medicines that treat a range of psychiatric, neurological and substance abuse disorders, including mental health disorders, Alzheimer’s disease, migraine headache and opioid use disorders in addition to rare diseases in the CNS category.
Clinilabs has global capabilities and conducts phase 2-3 clinical trials in Asia, through Clinilabs Asia Pacific, and Europe.
Clinilabs has conducted more than 720 CNS clinical trials in our 20+ year history and has played a pivotal role in the approval of 20 new therapies across 11 CNS indications. We are a patient-centric partner who shares your goal of speeding new CNS medicines to market to transform patients’ lives.
It is easy to get a thousand prescriptions, but hard to get one single remedy.
The best way to predict the future is to invent it.
One sometimes finds what one is not looking for.
If you think compliance is expensive, try non-compliance.
One never notices what has been done; one can only see what remains to be done.
Advances in drug development have led to greater improvement in the quality of human life than advances in all other fields combined.
The pace of discovery is going unbelievably fast.
I trust I may be enabled in the treatment of patients always to act with a single eye to their good.
I must say, I spend a lot of my time these days trying to persuade people that controlled trials are the only way to get information that’s reliable about drugs.
Good information is the best medicine.
The greatest joy in life is to accomplish. It is the getting, not the having. It is the giving, not the keeping.
There is so much more to be done; the patients are waiting.
All truths are easy to understand once they are discovered; the point is to discover them.
Remember the Three Princes of Serendip who went out looking for treasure? They didn’t find what they were looking for, but they kept finding things just as valuable. That’s serendipity, and our business [drugs] is full of it.
Let me tell you the secret that has led me to my goal. My strength lies solely in my tenacity.
The cures we want aren’t going to fall from the sky. We have to get ladders and climb up and get them.
Drugs don’t work in patients who don’t take them.
I am not accustomed to saying anything with certainty after only one or two observations.
I have no ideology. My ideology is health.
The reward for work well done is the opportunity to do more.
Without drugs, physicians would struggle to find relevance, and patients would suffer without hope.